Treatment of myelodysplastic syndrome, acute leukemia and chronic myelomonocytic leukemia with 5-azacytidine: Comparative results from a single centre

被引：0
|
作者：
Montalvao, A. [1 ]
机构：
[1] Unidade Local Saude Baixo Alentejo, Hematol, Beja, Portugal
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70352-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-305
引用
收藏
页码：S159 / S160
页数：2
相关论文
共 50 条
  • [1] Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports
    Rohon, Peter
    Vondrakova, Jana
    Jonasova, Anna
    Holzerova, Milena
    Jarosova, Marie
    Indrak, Karel
    CASE REPORTS IN HEMATOLOGY, 2012, 2012
  • [2] RESULTS IN ELDERLY CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENTS TREATED WITH 5-AZACYTIDINE
    Dunia, D. M.
    Nuria, G.
    Miguel, D.
    Jaime, A.
    Dolores, S.
    Dolores, M.
    Sonia, H.
    Blanca, P.
    HAEMATOLOGICA, 2016, 101 : 809 - 809
  • [3] TREATMENT OF PRIMARY AND THERAPY-RELATED MYELODYSPLASTIC SYNDROME WITH 5-AZACYTIDINE - COMPARATIVE RESULTS FROM A SINGLE CENTRE
    Augusto, J. S.
    Pierdomenico, F.
    Barroso, S.
    Almeida, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 357 - 357
  • [4] Maintenance with 5-Azacytidine for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients
    Oran, Betul
    de Lima, Marcos
    Garcia-Manero, Guillermo
    Thall, Peter F.
    Lin, Ruitao
    Alousi, Amin M.
    Hosing, Chitra
    Kebriaei, Partow
    Popat, Uday
    Giralt, Sergio
    Ahmed, Sairah
    Shpall, Elizabeth J.
    Andersson, Borje S.
    Bashir, Qaiser
    Ciurea, Stefan O.
    Rezvani, Katy
    Woodworth, Glenda
    Champlin, Richard E.
    BLOOD, 2018, 132
  • [5] TREATMENT OF ACUTE LEUKEMIA WITH 5-AZACYTIDINE
    MCCREDIE, KB
    FREIREIC.EJ
    RODRIGUE.V
    SULLIVAN, MP
    BURGESS, MA
    BODEY, GP
    BLOOD-THE JOURNAL OF HEMATOLOGY, 1972, 40 (06): : 975 - &
  • [6] 5-azacytidine treatment results in myelodysplastic syndrome
    Bakanay, S. M.
    Karakilic, E.
    Civriz-Bozdag, S.
    Arat, M.
    Ozcan, M.
    Gurman, G.
    Ilhan, O.
    Beksac, M.
    Konuk, N.
    Arslan, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Chronic myelomonocytic leukemia treated with 5-azacytidine - results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system
    Diamantopoulos, Panagiotis T.
    Kotsianidis, Ioannis
    Symeonidis, Argiris
    Pappa, Vassiliki
    Galanopoulos, Athanasios
    Gogos, Dimitrios
    Karakatsanis, Stamatios
    Papadaki, Helen
    Palla, Aikaterini
    Hatzimichael, Eleftheria
    Dimou, Maria
    Papageorgiou, Sotirios
    Delimpasis, Sosana
    Papaioannou, Maria
    Papoutselis, Menelaos
    Kourakli, Alexandra
    Tsokanas, Dimitrios
    Anagnostopoulos, Achilles
    Kontos, Christos K.
    Panayiotidis, Panayiotis
    Viniou, Nora-Athina
    LEUKEMIA & LYMPHOMA, 2019, 60 (07) : 1721 - 1730
  • [8] Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia
    Raza, Azral
    Mehdi, Munaza
    Mumtaz, Muhammad
    Ali, Fahad
    Lascher, Steven
    Galili, Naomi
    CANCER, 2008, 113 (07) : 1596 - 1604
  • [9] Paraneoplastic autoimmune phenomena in chronic myelomonocytic leukemia: successful treatment with 5-azacytidine and corticosteroids
    Vogt, B.
    Ben-Azzous, M.
    Jaeckle, S.
    Roessler, V.
    Kalla, J.
    Schneider, L.
    Henkes, M.
    la Rosee, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 200 - 200
  • [10] 5-Azacytidine in Chronic Myelomonocytic Leukemia: Case Report and Review of Literature
    Greco, M.
    Criscuolo, M.
    Fianchi, L.
    Fabiani, E.
    Pagano, L.
    Voso, M. T.
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2011, 3 (01):
12345